Promising results from first prenatal therapy for spinal muscular atrophy (IMAGE)

St. Jude Children's Research Hospital

Promising results from first prenatal therapy for spinal muscular atrophy

Caption

Prenatal therapy for spinal muscular atrophy (SMA) with risdiplam has shown promise in a first-of-its-kind study led by Richard Finkel, MD, St. Jude Center for Experimental Neurotherapeutics director and Department of Pediatric Medicine member, pictured.

Credit

St. Jude Children's Research Hospital

Usage Restrictions

No cropping

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.